17th Annual Practical Applications of New Agents in Oncology
Immune Targets and New Immunotherapy
February 5-6, 2016
Cancer remains a leading cause of death in the country. Educating healthcare professionals about newly available agents in oncology is critical. The conference will offer information on new immunotherapies and a discussion of new clinical studies for anticancer agents.
The conference will focus on the large number of new immune targets and immunotherapies that have been approved over the last several years, as well as those that are likely to be approved. Several world-renowned and local speakers will discuss how to incorporate these agents into standard clinical practice, providing guidance to the front-line clinicians, nurses and pharmacists regarding current or projected appropriate use of these therapeutics.
Who should attend?
The conference has an attractive case-based format and represents national points of view, making it a stimulating meeting for primary care and oncology clinicians, physicians, nurses, nurse practitioners, physician assistants, pharmacists and other health professionals and medical students.
Continuing education credits are offered for medical, nursing and pharmacy.